Consumer Affairs Authority Busts Illegal Medicine Stockpile Worth Over Rs. 10 Million in Colombo

Sri Lanka's Consumer Affairs Authority (CAA) has uncovered a significant cache of illegally imported pharmaceutical products and medical supplies during a raid on a warehouse in Colombo, with the total value of the seized goods exceeding Rs. 10 million.

Major Crackdown on Illegal Pharmaceutical Trade

The operation marks one of the more substantial enforcement actions taken against the unlawful importation of medicines in recent times, raising serious concerns about the circulation of unregulated pharmaceutical products within the country.

Authorities discovered the stockpile of medicines and medical items stored at the Colombo facility, all of which are believed to have entered the country through illegal channels, bypassing the regulatory oversight required for pharmaceutical imports in Sri Lanka.

Public Health Implications

The seizure highlights the ongoing threat posed by illegally imported medicines, which lack the quality assurance and safety checks mandated by Sri Lankan law. Such products carry significant risks for consumers, as their composition, storage conditions, and expiry status cannot be verified through official channels.

• Pharmaceutical products and medical items worth over Rs. 10 million were recovered
• The goods were found stored at a warehouse located in Colombo
• All seized items are believed to have been imported through illegal means

The CAA reiterated its commitment to protecting consumers from substandard and illegally circulated goods, warning that further enforcement operations would continue across the island.

Investigations Ongoing

The Consumer Affairs Authority has launched a formal investigation into the matter and is working to identify those responsible for importing and storing the illicit pharmaceutical stock. Legal proceedings are expected to follow as the case develops.

Members of the public are urged to purchase medicines only from licensed pharmacies and registered suppliers, and to report any suspicious activity related to the sale of unregulated medical products to the relevant authorities.